What to look for in novel CLL therapies
An update on kinase inhibitors from EHA 2017
Research on HDACs for multiple myeloma: studying immunological effects and resistance models
What are the current treatment options for Waldenström’s macroglobulinemia?
Clinically relevant side effects of BiTE immunotherapy and other T-cell therapies